Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.3974 per EA under NDC 69367033730. Its NADAC has been published 261 times since Oct 6, 2021.
FDA first approved this application on Feb 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367033730
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213485FDA Approved
2/16/2021
TE Code
AB
On Market Since
7/26/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 261 times since Oct 6, 2021, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3974 per EA |
|---|---|
| All-time high | $1.3194 (Nov 10, 2021) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.3974 |
| Median price | $0.5940 |
| Average price | $0.6773 |
| Largest weekly change | +50.9% (Feb 22, 2023) |
| Weeks tracked | 261 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paroxetine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.3974 per EA (NDC 69367033730), effective Sep 30, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 57.5%. It has been tracked across 261 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Oct 6, 2021, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $1.3194 (Nov 10, 2021), with a median of $0.5940 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE ER 37.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 69367033730) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.